Within TNBC specifically, harnessing or enhancing the CXCL9–CXCR3 interaction could potentially strengthen immune infiltration and cytotoxicity, laying the groundwork for novel immunotherapeutic strategies that boost anti-tumor immunity (28). Here, CXCL9 is linked to neoplasm.